{
  "case_id": "Case_5",
  "model_id": "microsoft/wizardlm-2-8x22b",
  "content": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Parkinson's Disease\",\n        \"confidence\": 0.7,\n        \"icd_code\": \"G20\",\n        \"reasoning\": \"Progressive neurological symptoms of tremor, bradykinesia, and rigidity with onset after the patient's return from a rural area, which could have environmental exposures contributing to the development of Parkinsonism.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Manganism\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"Unknown\",\n            \"reasoning\": \"Exposure to manganese, which is common in certain industrial settings and can present with similar extrapyramidal symptoms.\"\n        },\n        {\n            \"name\": \"Secondary Parkinsonism due to toxic exposure\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"G21.1\",\n            \"reasoning\": \"Environmental toxins such as pesticides or other neurotoxic substances could lead to parkinsonian symptoms.\"\n        },\n        {\n            \"name\": \"Essential Tremor\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"G25.0\",\n            \"reasoning\": \"Tremor is a prominent feature, but the presence of bradykinesia and rigidity makes this less likely.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Progressive neurological symptoms including tremor, bradykinesia, and rigidity\",\n        \"Subtle signal abnormalities in basal ganglia on MRI\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Blood tests for heavy metals and environmental toxins\",\n            \"purpose\": \"To rule out manganism or toxic exposures\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Cerebrospinal fluid analysis\",\n            \"purpose\": \"To assess for inflammatory or infectious processes\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"DaTscan (Dopamine Transporter Scan)\",\n            \"purpose\": \"To evaluate the integrity of dopaminergic neurons in the basal ganglia\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Initiate supportive care\",\n            \"Refer to neurology for further evaluation\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Levodopa/Carbidopa\",\n                \"dose\": \"Starting at 100/25 mg three times daily, titrate as needed\",\n                \"route\": \"PO\",\n                \"duration\": \"Long-term\",\n                \"rationale\": \"First-line treatment for Parkinson's Disease symptoms\"\n            }\n        ],\n        \"monitoring\": [\n            \"Response to medication\",\n            \"Frequency: Every 3-6 months or as clinically indicated\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Neurology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Expertise in movement disorders is needed for diagnosis confirmation and management\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapid progression of symptoms\",\n        \"Development of atypical features for Parkinson's Disease such as early cognitive decline or autonomic dysfunction\"\n    ],\n    \"patient_education\": [\n        \"Educate about the nature of Parkinson's Disease and its management\",\n        \"Importance of avoiding further exposure to potential environmental toxins\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"In 1-2 weeks after initial medication adjustment, then every 3-6 months\",\n        \"conditions\": \"Worsening of symptoms, development of side effects from medication, or any new red flag symptoms\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\n        \"Exact environmental exposures during the patient's time in Bangladesh\",\n        \"The patient's response to initial treatment with levodopa\"\n    ]\n}\n```",
  "latency": 32.3177490234375,
  "timestamp": "2025-08-10T01:21:06.464883",
  "cached_at": "2025-08-10T01:21:06.464892"
}